| Bioactivity | Sifuvirtide (SFT) is a potent HIV fusion inhibitor. Sifuvirtide inhibits HIV-1 mediated cell fusion in a dose-dependent manner and is highly potent against infection by primary and laboratory-adapted HIV-1 isolates of multiple genotypes. Sifuvirtide can be used in the research of anti-HIV drugs[1]. |
| CAS | 857094-21-4 |
| Sequence | Ac-Ser-Trp-Glu-Thr-Trp-Glu-Arg-Glu-Ile-Glu-Asn-Tyr-Thr-Arg-Gln-Ile-Tyr-Arg-Ile-Leu-Glu-Glu-Ser-Gln-Glu-Gln-Gln-Asp-Arg-Asn-Glu-Arg-Asp-Leu-Leu-Glu |
| Shortening | Ac-SWETWEREIENYTRQIYRILEESQEQQDRNERDLLE |
| Formula | C203H309N59O72 |
| Molar Mass | 4728.05 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang R R, et al. Sifuvirtide, a potent HIV fusion inhibitor peptide[J]. Biochemical and biophysical research communications, 2009, 382(3): 540-544. |
Sifuvirtide
CAS: 857094-21-4 F: C203H309N59O72 W: 4728.05
Sifuvirtide (SFT) is a potent HIV fusion inhibitor. Sifuvirtide inhibits HIV-1 mediated cell fusion in a dose-dependent
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.